Origin Materials And 2 Additional Promising Penny Stocks
The US stock exchange has continued a wave of optimism, the S&P 500 recently reached new peaks due to positive trade agreements and expectation of earnings reports from large companies. In such a live market, investors often look beyond large -lid stocks to investigate opportunities in smaller segments such as penny stocks. Although “Penny Stocks” seems to be a outdated period, they still represent a living space for investment that offers potential growth at lower price points when they are still supported by strong financial situations.
|
Name |
Stock price |
Market value |
Financial health degree |
|
Wateervrop (WDH) |
$ 1.67 |
$ 614.83m |
★★★★★ique |
|
Curiositystream (Curi) |
4.60 $ |
$ 258.53m |
★★★★★ique |
|
WM Technology (Maps) |
$ 0.9931 |
$ 161.13m |
★★★★★ique |
|
Excellent (Perf) |
$ 2.51 |
266.84m $ |
★★★★★ique |
|
Tuniu (Tour) |
$ 0.9326 |
$ 101.15m |
★★★★★ique |
|
Safe finders (SB) |
4.14 $ |
416.4m $ |
★★★★ ☆☆ |
|
Cardno (Cold.F) |
$ 0.1701 |
6,64 million dollars |
★★★★★ique |
|
Bab (BABB) |
$ 0.8009 |
6,14 million dollars |
★★★★★ique |
|
LIFE BRANDS (LCUT) |
4.65 $ |
$ 103.33m |
★★★★★ ☆ |
|
TANDY LEATHER FACTORY (TLF) |
$ 3.44 |
28.6 million dollars |
★★★★★ique |
Click here to see the full list of 415 stocks from our US Penny Stocks Screener.
Discover a few outstanding options from the results on the screen.
Simply Wall ST financial health degree: ★★★★ ☆☆
Overview: Origin Materials, Inc. It operates as a carbon-negative material company and has a market value of approximately $ 89.61 million.
Operations: The company generates revenue from a special chemical segment of $ 29.89 million.
Market value: 89,61 million dollars
Origin Materials offers a mixed picture for investors interested in Penny Stocks. The company successfully reduced its debt for five years from 44.8% to 1.1% and kept more cash than total debt, which showed financial caution. However, with a return of equinity of -30.59%, it remains unprofitable and gains have decreased by 26.6% annually in the last five years. Nevertheless, Origin’s short -term assets easily cover both short and long -term obligations and provide some financial stability in the midst of an inexperienced committee with high share price volatility and an average period of 2.2 years of duty.
Simply Wall ST financial health degree: ★★★★★ ☆
Overview: Cassava Sciences, Inc. is a clinical -gradual biotechnology company with a market value of approximately $ 111.11 million, focusing on development of drugs for neurodegenerative diseases.
Operations: Cassava Sciences, Inc. It currently does not report any income segment.
